510(k) Report

510(k) · Cleared

Cleared

Aview LCS

K193220510(k) TraditionalCleared May 5, 2020166-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Coreline Soft Co., Ltd. · LLZ System, Image Processing, Radiological

Cleared on May 5, 2020 as substantially equivalent to K162484 (Philips Medical Systems Nederland B.V., 2017) after a 166-day review. Its family tree reaches back 9 generations to 1991. 1 later device descends from it.

Decided
May 5, 2020
Review
166 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 9 generations to K913770 (1991). 35 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 9 generations backK913770 Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co. · 1991
  2. 5 generations between
  3. 3 generations backK043333 VITREA2, Version 3.7 Medical Image Processing SystemVital Images, Inc. · 2004 · Recalled
  4. 2 generations backK151283 Lung Analysis SoftwareVital Images, Inc. · 2015
  5. 1 generation backK162484 Lung Nodule Assessment and Comparison Option (LNA)Philips Medical Systems Nederland B.V. · 2017
  6. This deviceK193220 Aview LCSCoreline Soft Co., Ltd. · 2020
  7. Descendant · cites it directly · 0 of its ownK201710 A View LCSCoreline Soft Co., Ltd. · 2020
Show all 9 generations
  1. Root · 9 generations backK913770 Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co. · 1991
  2. 8 generations backK960613 GE Advantage Windows Review WorkstationGE Medical Systems · 1996
  3. 7 generations backK020483 Advantage Workstation 4.1GE Medical Systems · 2002 · Recalled
  4. 6 generations backK023003 Imagechecker-CT WorkstationR2 Technology, Inc. · 2002
  5. 5 generations backK032748 VITREA2, Version 3.4 Medical Image Processing SoftwareVital Images, Inc. · 2003 · Recalled
  6. 4 generations backK040305 VITREA2 Version 3.5Vital Images, Inc. · 2004
  7. 3 generations backK043333 VITREA2, Version 3.7 Medical Image Processing SystemVital Images, Inc. · 2004 · Recalled
  8. 2 generations backK151283 Lung Analysis SoftwareVital Images, Inc. · 2015
  9. 1 generation backK162484 Lung Nodule Assessment and Comparison Option (LNA)Philips Medical Systems Nederland B.V. · 2017
  10. This deviceK193220 Aview LCSCoreline Soft Co., Ltd. · 2020

Most influential descendants

Showing 1 of 1 · See all
  • K201710A View LCSCoreline Soft Co., Ltd. · 2020 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K913770Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co.1991—
−8K960613GE Advantage Windows Review WorkstationGE Medical Systems1996—
−7K020483Advantage Workstation 4.1GE Medical Systems20022
−6K023003Imagechecker-CT WorkstationR2 Technology, Inc.2002—
−5K032748VITREA2, Version 3.4 Medical Image Processing SoftwareVital Images, Inc.20032
−4K040305VITREA2 Version 3.5Vital Images, Inc.2004—
−3K043333VITREA2, Version 3.7 Medical Image Processing SystemVital Images, Inc.20041
−2K151283Lung Analysis SoftwareVital Images, Inc.2015—
−1K162484Lung Nodule Assessment and Comparison Option (LNA)Philips Medical Systems Nederland B.V.2017—
0 (this device)K193220Aview LCSCoreline Soft Co., Ltd.2020—
+1K201710A View LCSCoreline Soft Co., Ltd.2020—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199310
199440
199510
199630
199720
199830
199910
200020
200160
200220
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
FIG. 1 — Lineage of K193220, 1991–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K162484Lung Nodule Assessment and Comparison Option (LNA)
Summary page 4
…l (21CFR 892.2050) Regulatory Class: II Product Code: LLZ, JAK 3 PREDICATE DEVICE Lung Nodule Assessment and Comparison Option by Philips Medical System Nederland B.V. (K162484) Name of Device: Lung Nodule Assessment and Comparison Option (LNA) Common or Usual Name: Lung Nodule Assessment and Comparison…
Philips Medical Systems Nederland B.V.2017—
†K151283Lung Analysis SoftwareVital Images, Inc.2015—
†K171199AVIEWCoreline Soft Co., Ltd.2018—
†K043617Imagechecker CT Cad Software SystemHologic, Inc.2007—

Also cleared against K162484: 5 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K201710A View LCSCoreline Soft Co., Ltd.20200

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 6 companies; a new generation was cleared every 1.3 years on median.
  • 8 of the 35 ancestors have a recall of any class.
  • Of its descendants, K201710 (Coreline Soft Co., Ltd., 2020) has gone furthest, with 0 descendants of its own.
  • 5 other devices also cite its predicate K162484.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

AVIEW LCS is intended for the review and analysis and reporting of thoracic CT images for the purpose of characterizing nodules in the lung in a single study, or over the time course of several thoracic studies. Characterizations include nodule type, location of the nodule and measurements such as size (major axis, minor axis), estimated effective diameter from the volume of the nodule, the volume of the nodule, Mean HU (the average value of the CT pixel…

Read the full statement (179 words)

AVIEW LCS is intended for the review and analysis and reporting of thoracic CT images for the purpose of characterizing nodules in the lung in a single study, or over the time course of several thoracic studies. Characterizations include nodule type, location of the nodule and measurements such as size (major axis, minor axis), estimated effective diameter from the volume of the nodule, the volume of the nodule, Mean HU (the average value of the CT pixel inside the nodule in HU), Minimum HU, Max HU, mass (mass calculated from the CT pixel value), and volumetric measures (Solid Major; length of the longest diameter measured in 3D for a solid portion of the nodule. Solid 2nd Major: The length of the longest diameter of the solid part, measured in sections perpendicular to the Major axis of the solid portion of the nodule), VDT (Volume doubling time), and Lung-RADS (classification proposed to aid with findings). The system automatically performs the measurement, allowing lung nodules and measurements to be displayed and, also integrate with FDA certified Mevis CAD (Computer-aided detection) (K043617).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K193220: Aview LCS.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K193220

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026